{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:16:27Z","timestamp":1790014587051,"version":"4.0.1"},"reference-count":92,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T00:00:00Z","timestamp":1535500800000},"content-version":"vor","delay-in-days":120,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Portuguesa de Cardiologia"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.repc.2017.07.010","type":"journal-article","created":{"date-parts":[[2018,4,7]],"date-time":"2018-04-07T17:52:17Z","timestamp":1523123537000},"page":"435-446","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Drug-induced life-threatening arrhythmias and sudden cardiac death: A clinical perspective of long QT, short QT and Brugada syndromes"],"prefix":"10.1016","volume":"37","author":[{"given":"Diogo","family":"Ramalho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.repc.2017.07.010_bib0465","first-page":"1601","volume":"17","author":"Priori","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.repc.2017.07.010_bib0470","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s12012-014-9255-1","article-title":"Sudden cardiac death in young adult","volume":"14","author":"Silva","year":"2014","journal-title":"Cardiovasc Toxicol"},{"key":"10.1016\/j.repc.2017.07.010_bib0475","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/S0140-6736(12)61413-5","article-title":"Ventricular arrhythmias and sudden cardiac death","volume":"380","author":"John","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.repc.2017.07.010_bib0480","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1139\/cjpp-2015-0366","article-title":"Pathophysiology and prevention of sudden cardiac death","volume":"94","author":"Goyal","year":"2016","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.repc.2017.07.010_bib0485","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1093\/eurheartj\/eht054","article-title":"Sudden cardiac arrest associated with use of a non-cardiac drug that reduces cardiac excitability: evidence from bench, bedside, and community","volume":"34","author":"Bardai","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2017.07.010_bib0490","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.hrthm.2012.12.002","article-title":"Antipsychotic drugs are associated with pulseless electrical activity: the Oregon Sudden Unexpected Death Study","volume":"10","author":"Teodorescu","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.repc.2017.07.010_bib0495","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.jacc.2012.01.036","article-title":"Ventricular arrhythmias in the absence of structural heart disease","volume":"59","author":"Prystowsky","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2017.07.010_bib0500","first-page":"1269","article-title":"Antipsychotic medication and QT prolongation","volume":"31","author":"Chohan","year":"2015","journal-title":"Pak J Med Sci"},{"key":"10.1016\/j.repc.2017.07.010_bib0505","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2165\/11587800-000000000-00000","article-title":"Assessing QT interval prolongation and its associated risks with antipsychotics","volume":"25","author":"Nielsen","year":"2011","journal-title":"CNS Drugs"},{"key":"10.1016\/j.repc.2017.07.010_bib0510","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4330\/wjc.v5.i6.175","article-title":"Mechanisms of drug-induced proarrhythmia in clinical practice","volume":"5","author":"Konstantopoulou","year":"2013","journal-title":"World J Cardiol"},{"key":"10.1016\/j.repc.2017.07.010_bib0515","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jacc.2010.01.001","article-title":"Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation","volume":"55","author":"Drew","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2017.07.010_bib0520","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1056\/NEJMra032426","article-title":"Drug-induced prolongation of the QT interval","volume":"350","author":"Roden","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2017.07.010_bib0525","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1253\/circj.CJ-15-0322","article-title":"Unveiling specific triggers and precipitating factors for fatal cardiac events in inherited arrhythmia syndromes","volume":"79","author":"Nakajima","year":"2015","journal-title":"Circ J"},{"key":"10.1016\/j.repc.2017.07.010_bib0530","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s40264-015-0316-6","article-title":"Pharmacogenetics of drug-induced QT interval prolongation: an update","volume":"38","author":"Niemeijer","year":"2015","journal-title":"Drug Saf"},{"key":"10.1016\/j.repc.2017.07.010_bib0535","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1517\/14656566.2014.936380","article-title":"Cardiac sodium channels and inherited electrophysiological disorders: an update on the pharmacotherapy","volume":"15","author":"van Hoeijen","year":"2014","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.repc.2017.07.010_bib0540","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/europace\/eur245","article-title":"HRS\/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)","volume":"13","author":"Ackerman","year":"2011","journal-title":"Europace"},{"key":"10.1016\/j.repc.2017.07.010_bib0545","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1161\/CIRCULATIONAHA.111.062182","article-title":"QTc behavior during exercise and genetic testing for the long-QT syndrome","volume":"124","author":"Schwartz","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2017.07.010_bib0550","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000047299","article-title":"Idiopathic short QT interval: a new clinical syndrome?","volume":"94","author":"Gussak","year":"2000","journal-title":"Cardiology"},{"key":"10.1016\/j.repc.2017.07.010_bib0555","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1053\/j.jvca.2015.07.026","article-title":"Sudden cardiac death and disorders of the QT interval: anesthetic implications and focus on perioperative management","volume":"29","author":"Ramakrishna","year":"2015","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.repc.2017.07.010_bib0560","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/0735-1097(92)90253-J","article-title":"Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report","volume":"20","author":"Brugada","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2017.07.010_bib0565","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cpcardiol.2015.06.002","article-title":"Brugada syndrome: clinical, genetic, molecular, cellular, and ionic aspects","volume":"41","author":"Antzelevitch","year":"2016","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.repc.2017.07.010_bib0570","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.joa.2016.07.012","article-title":"Genetics of Brugada syndrome","volume":"32","author":"Juang","year":"2016","journal-title":"J Arrhythm"},{"key":"10.1016\/j.repc.2017.07.010_bib0575","author":"Antzelevitch","year":"2016","journal-title":"Europace"},{"key":"10.1016\/j.repc.2017.07.010_bib0580","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.hrthm.2013.05.014","article-title":"HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013","volume":"10","author":"Priori","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.repc.2017.07.010_bib0585","unstructured":"Woosley R, Heise CW, Romero KA. QTdrugs List. AZCERT, Inc., 1822 Innovation Park Dr., Oro Valley, AZ 85755. www.CredibleMeds.org [accessed 12.01.17]."},{"key":"10.1016\/j.repc.2017.07.010_bib0590","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/europace\/eut018","article-title":"Safe drug use in long QT syndrome and Brugada syndrome: comparison of website statistics","volume":"15","author":"Postema","year":"2013","journal-title":"Europace"},{"key":"10.1016\/j.repc.2017.07.010_bib0595","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nrcardio.2015.110","article-title":"Drug-induced proarrhythmia: risk factors and electrophysiological mechanisms","volume":"13","author":"Frommeyer","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.repc.2017.07.010_bib0600","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10840-013-9779-5","article-title":"Genetics of congenital and drug-induced long QT syndromes: current evidence and future research perspectives","volume":"37","author":"Mahida","year":"2013","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.repc.2017.07.010_bib0605","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.hlc.2014.03.016","article-title":"Effect of smoking on Tp-e interval, Tp-e\/QT and Tp-e\/QTc ratios as indices of ventricular arrhythmogenesis","volume":"23","author":"Tasolar","year":"2014","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.repc.2017.07.010_bib0610","doi-asserted-by":"crossref","first-page":"973","DOI":"10.17219\/acem\/28114","article-title":"The effects of cigarette smoking on the Tp-e interval, Tp-e\/QT ratio and Tp-e\/QTc ratio","volume":"24","author":"Ilgenli","year":"2015","journal-title":"Adv Clin Exp Med"},{"key":"10.1016\/j.repc.2017.07.010_bib0615","first-page":"465","article-title":"Impact of psychotropic drugs on QT interval dispersion in adult patients","volume":"102","author":"Claudio Bde","year":"2014","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.repc.2017.07.010_bib0620","first-page":"23","article-title":"Psychiatric medications and sudden cardiac death: putting the risk in perspective","volume":"53","author":"Howland","year":"2015","journal-title":"J Psychosoc Nurs Ment Health Serv"},{"key":"10.1016\/j.repc.2017.07.010_bib0625","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1136\/hrt.2009.188367","article-title":"Non-cardiovascular drugs that inhibit hERG-encoded potassium channels and risk of sudden cardiac death","volume":"97","author":"van Noord","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.repc.2017.07.010_bib0630","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s40291-015-0137-4","article-title":"A possible mechanistic link between the CYP2C19 genotype, the methadone metabolite ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidene (EDDP), and methadone-induced corrected QT interval prolongation in a pilot study","volume":"19","author":"Carlquist","year":"2015","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.repc.2017.07.010_bib0635","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1472-8206.2010.00871.x","article-title":"QT interval prolongation: prevalence, risk factors and pharmacovigilance data among methadone-treated patients in France","volume":"25","author":"Perrin-Terrin","year":"2011","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.repc.2017.07.010_bib0640","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/j.jacc.2015.09.029","article-title":"The role of macrolide antibiotics in increasing cardiovascular risk","volume":"66","author":"Cheng","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2017.07.010_bib0645","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/1574886311308010009","article-title":"Domperidone in Parkinson's disease: a perilous arrhythmogenic or the gold standard?","volume":"8","author":"Lertxundi","year":"2013","journal-title":"Curr Drug Saf"},{"key":"10.1016\/j.repc.2017.07.010_bib0650","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3389\/fphar.2012.00076","article-title":"Sudden death of cardiac origin and psychotropic drugs","volume":"3","author":"Timour","year":"2012","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.repc.2017.07.010_bib0655","first-page":"217","article-title":"Nitric oxide synthase 1 adaptor protein, an emerging new genetic marker for QT prolongation and sudden cardiac death","volume":"29","author":"Chang","year":"2013","journal-title":"Acta Cardiol Sin"},{"key":"10.1016\/j.repc.2017.07.010_bib0660","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/aas.12257","article-title":"Drug-induced long QT syndrome and fatal arrhythmias in the intensive care unit","volume":"58","author":"Beitland","year":"2014","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.repc.2017.07.010_bib0665","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1177\/070674371506000502","article-title":"Impact of age and sex on QT prolongation in patients receiving psychotropics","volume":"60","author":"Rabkin","year":"2015","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.repc.2017.07.010_bib0670","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4037\/ccn2012900","article-title":"Acquired long QT syndrome: frequency, onset, and risk factors in intensive care patients","volume":"32","author":"Kozik","year":"2012","journal-title":"Crit Care Nurse"},{"key":"10.1016\/j.repc.2017.07.010_bib0675","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4070\/kcj.2014.44.2.122","article-title":"A case of sudden cardiac death due to pilsicainide-induced torsades de pointes","volume":"44","author":"Nakatani","year":"2014","journal-title":"Korean Circ J"},{"key":"10.1016\/j.repc.2017.07.010_bib0680","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/europace\/eus400","article-title":"The risk of sudden cardiac death in patients with non-ST elevation acute coronary syndrome and prolonged QTc interval: effect of ranolazine","volume":"15","author":"Karwatowska-Prokopczuk","year":"2013","journal-title":"Europace"},{"key":"10.1016\/j.repc.2017.07.010_bib0685","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ajem.2014.09.048","article-title":"Risk factors for QT prolongation associated with acute psychotropic drug overdose","volume":"33","author":"Miura","year":"2015","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.repc.2017.07.010_bib0690","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/PAF.0000000000000205","article-title":"Cardiac toxicity in selective serotonin reuptake inhibitor users","volume":"36","author":"Lusetti","year":"2015","journal-title":"Am J Forensic Med Pathol"},{"key":"10.1016\/j.repc.2017.07.010_bib0695","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.4088\/JCP.13r08672","article-title":"Meta-analysis of selective serotonin reuptake inhibitor-associated QTc prolongation","volume":"75","author":"Beach","year":"2014","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.repc.2017.07.010_bib0700","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1176\/appi.ajp.2013.12060860","article-title":"Drug-induced long QT in adult psychiatric inpatients: the 5-year cross-sectional ECG Screening Outcome in Psychiatry study","volume":"170","author":"Girardin","year":"2013","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.repc.2017.07.010_bib0705","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.amjmed.2011.12.002","article-title":"Citalopram, QTc interval prolongation, and torsade de pointes. How should we apply the recent FDA ruling?","volume":"125","author":"Vieweg","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.repc.2017.07.010_bib0710","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1177\/1060028014550645","article-title":"Risk of QT\/QTc prolongation among newer non-SSRI antidepressants","volume":"48","author":"Jasiak","year":"2014","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.repc.2017.07.010_bib0715","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/pds.2181","article-title":"Antidepressants and the risk of sudden cardiac death and ventricular arrhythmia","volume":"20","author":"Leonard","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.repc.2017.07.010_bib0720","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001568","article-title":"Antipsychotic drugs and the risk of ventricular arrhythmia and\/or sudden cardiac death: a nation-wide case-crossover study","volume":"4","author":"Wu","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.repc.2017.07.010_bib0725","doi-asserted-by":"crossref","first-page":"e81208","DOI":"10.1371\/journal.pone.0081208","article-title":"Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe","volume":"8","author":"Raschi","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.repc.2017.07.010_bib0730","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s40264-013-0032-z","article-title":"Antipsychotics and torsadogenic risk: signals emerging from the US FDA Adverse Event Reporting System database","volume":"36","author":"Poluzzi","year":"2013","journal-title":"Drug Saf"},{"key":"10.1016\/j.repc.2017.07.010_bib0735","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1093\/eurheartj\/ehu100","article-title":"Risk of arrhythmia induced by psychotropic medications: a proposal for clinical management","volume":"35","author":"Fanoe","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2017.07.010_bib0740","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s40264-015-0353-1","article-title":"The contribution of national spontaneous reporting systems to detect signals of torsadogenicity: issues emerging from the ARITMO project","volume":"39","author":"Raschi","year":"2016","journal-title":"Drug Saf"},{"issue":"Suppl","key":"10.1016\/j.repc.2017.07.010_bib0745","first-page":"1","article-title":"Antipsychotics and the risks of sudden cardiac death and all-cause death: cohort studies in Medicaid and dually-eligible Medicaid-Medicare beneficiaries of five states","volume":"10","author":"Leonard","year":"2013","journal-title":"J Clin Exp Cardiolog"},{"key":"10.1016\/j.repc.2017.07.010_bib0750","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/hup.1221","article-title":"QTc prolongation: is clozapine safe? Study of 82 cases before and after clozapine treatment","volume":"26","author":"Grande","year":"2011","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.repc.2017.07.010_bib0755","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1176\/appi.ajp.2010.08040484","article-title":"Comparative mortality associated with ziprasidone and olanzapine in real-world use among 18,154 patients with schizophrenia: The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC)","volume":"168","author":"Strom","year":"2011","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.repc.2017.07.010_bib0760","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/pds.2185","article-title":"Methodological challenges in the coding and adjudication of sudden deaths in a large simple trial with observational follow-up: the ziprasidone observational study of cardiac outcomes (ZODIAC)","volume":"20","author":"Geier","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.repc.2017.07.010_bib0765","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1517\/14740338.2011.560114","article-title":"Drug safety evaluation of ziprasidone","volume":"10","author":"Citrome","year":"2011","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.repc.2017.07.010_bib0770","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1007\/s00213-015-4024-9","article-title":"The cardiac safety of aripiprazole treatment in patients at high risk for torsade: a systematic review with a meta-analytic approach","volume":"232","author":"Polcwiartek","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.repc.2017.07.010_bib0775","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1517\/14740338.2016.1161021","article-title":"Cardiovascular safety of antipsychotics: a clinical overview","volume":"15","author":"Polcwiartek","year":"2016","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.repc.2017.07.010_bib0780","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1177\/2045125313510194","article-title":"Quetiapine, QTc interval prolongation, and torsade de pointes: a review of case reports","volume":"4","author":"Hasnain","year":"2014","journal-title":"Ther Adv Psychopharmacol"},{"key":"10.1016\/j.repc.2017.07.010_bib0785","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/JCP.0b013e31823f6f21","article-title":"Increased risk of antipsychotic-related QT prolongation during nighttime: a 24-hour holter electrocardiogram recording study","volume":"32","author":"Watanabe","year":"2012","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.repc.2017.07.010_bib0790","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/hup.1258","article-title":"QT prolongation of the antipsychotic risperidone is predominantly related to its 9-hydroxy metabolite paliperidone","volume":"27","author":"Suzuki","year":"2012","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.repc.2017.07.010_bib0795","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/bcp.12955","article-title":"Prescribing pattern of antipsychotic drugs during the years 1996\u20132010: a population-based database study in Europe with a focus on torsadogenic drugs","volume":"82","author":"Oteri","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.repc.2017.07.010_bib0800","doi-asserted-by":"crossref","first-page":"375020","DOI":"10.1155\/2013\/375020","article-title":"QTc prolongation in patients acutely admitted to hospital for psychosis and treated with second generation antipsychotics","volume":"2013","author":"Johnsen","year":"2013","journal-title":"Schizophr Res Treatment"},{"key":"10.1016\/j.repc.2017.07.010_bib0805","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1089\/cap.2011.0024","article-title":"Antipsychotic drug administration does not correlate with prolonged rate-corrected QT interval in children and adolescents: results from a nested case-control study","volume":"21","author":"Correll","year":"2011","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.repc.2017.07.010_bib0810","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1056\/NEJMoa1003833","article-title":"Azithromycin and the risk of cardiovascular death","volume":"366","author":"Ray","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2017.07.010_bib0815","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1370\/afm.1601","article-title":"Azithromycin and levofloxacin use and increased risk of cardiac arrhythmia and death","volume":"12","author":"Rao","year":"2014","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.repc.2017.07.010_bib0820","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3346\/jkms.2013.28.5.788","article-title":"Sudden cardiac arrest during anesthesia in a 30-month-old boy with syndactyly: a case of genetically proven Timothy syndrome","volume":"28","author":"An","year":"2013","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.repc.2017.07.010_bib0825","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s40261-015-0360-0","article-title":"Domperidone and risk of ventricular arrhythmia and cardiac death: a systematic review and meta-analysis","volume":"36","author":"Leelakanok","year":"2016","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.repc.2017.07.010_bib0830","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s40264-015-0338-0","article-title":"Risk of out-of-hospital sudden cardiac death in users of domperidonem proton pump inhibitors, or metoclopramide: a population-based nested case-control study","volume":"38","author":"Arana","year":"2015","journal-title":"Drug Saf"},{"key":"10.1016\/j.repc.2017.07.010_bib0835","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/acem.12836","article-title":"Intravenous ondansetron and the QT interval in adult emergency department patients: an observational study","volume":"23","author":"Moffett","year":"2016","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.repc.2017.07.010_bib0840","doi-asserted-by":"crossref","first-page":"e0119551","DOI":"10.1371\/journal.pone.0119551","article-title":"Pro-arrhythmic potential of oral antihistamines (H1): combining adverse event reports with drug utilization data across Europe","volume":"10","author":"Poluzzi","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.repc.2017.07.010_bib0845","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11936-014-0303-8","article-title":"Chemotherapy and QT prolongation: overview with clinical perspective","volume":"16","author":"Kim","year":"2014","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"10.1016\/j.repc.2017.07.010_bib0850","doi-asserted-by":"crossref","first-page":"35589","DOI":"10.18632\/oncotarget.5853","article-title":"What links BRAF to the heart function? New insights from the cardiotoxicity of BRAF inhibitors in cancer treatment","volume":"6","author":"Bronte","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.repc.2017.07.010_bib0855","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40263-012-0019-9","article-title":"Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder","volume":"27","author":"Martinez-Raga","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.repc.2017.07.010_bib0860","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1471-2261-12-41","article-title":"Do prescription stimulants increase the risk of adverse cardiovascular events?: A systematic review","volume":"12","author":"Westover","year":"2012","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.repc.2017.07.010_bib0865","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1176\/appi.ajp.2011.11010125","article-title":"Methylphenidate and risk of serious cardiovascular events in adults","volume":"169","author":"Schelleman","year":"2012","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.repc.2017.07.010_bib0870","doi-asserted-by":"crossref","first-page":"e17584","DOI":"10.1371\/journal.pone.0017584","article-title":"Coffee, alcohol, smoking, physical activity and QT interval duration: results from the Third National Health and Nutrition Examination Survey","volume":"6","author":"Zhang","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.repc.2017.07.010_bib0875","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jelectrocard.2010.08.007","article-title":"Ginseng: a potential cause of long QT","volume":"44","author":"Torbey","year":"2011","journal-title":"J Electrocardiol"},{"key":"10.1016\/j.repc.2017.07.010_bib0880","doi-asserted-by":"crossref","first-page":"241","DOI":"10.5543\/tkda.2013.72547","article-title":"Polymorphic ventricular tachycardia (Torsades de pointes) due to licorice root tea","volume":"41","author":"Ozturk","year":"2013","journal-title":"Turk Kardiyol Dern Ars"},{"key":"10.1016\/j.repc.2017.07.010_bib0885","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1476-5381.2009.00191.x","article-title":"Drug-induced QT interval shortening: potential harbinger of proarrhythmia and regulatory perspectives","volume":"159","author":"Shah","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.repc.2017.07.010_bib0890","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.hrthm.2012.01.006","article-title":"Drug-induced QT-interval shortening following antiepileptic treatment with oral rufinamide","volume":"9","author":"Schimpf","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.repc.2017.07.010_bib0895","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1111\/pace.12234","article-title":"Drug-induced Brugada syndrome by noncardiac agents","volume":"36","author":"Letsas","year":"2013","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.repc.2017.07.010_bib0900","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2796.2011.02395.x","article-title":"The safety of flecainide treatment of atrial fibrillation: long-term incidence of sudden cardiac death and proarrhythmic events","volume":"270","author":"Almroth","year":"2011","journal-title":"J Intern Med"},{"key":"10.1016\/j.repc.2017.07.010_bib0905","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/01.mjt.0000433948.16654.91","article-title":"Brugada electrocardiogram pattern \u201cunmasked\u201d by amiodarone infusion","volume":"21","author":"Bajaj","year":"2014","journal-title":"Am J Ther"},{"key":"10.1016\/j.repc.2017.07.010_bib0910","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/heartjnl-2014-305664","article-title":"Sudden cardiac death is associated both with epilepsy and with use of antiepileptic medications","volume":"101","author":"Bardai","year":"2015","journal-title":"Heart"},{"key":"10.1016\/j.repc.2017.07.010_bib0915","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.seizure.2016.06.004","article-title":"Polytherapy with sodium channel-blocking antiepileptic drugs is associated with arrhythmogenic ST-T abnormality in patients with epilepsy","volume":"40","author":"Ishizue","year":"2016","journal-title":"Seizure"},{"key":"10.1016\/j.repc.2017.07.010_bib0920","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1016\/j.jemermed.2015.08.008","article-title":"Type 1 Brugada pattern associated with nicotine toxicity","volume":"49","author":"Ondrejka","year":"2015","journal-title":"J Emerg Med"}],"container-title":["Revista Portuguesa de Cardiologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0870255117300586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0870255117300586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:06:02Z","timestamp":1760108762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0870255117300586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":92,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0870255117300586"],"URL":"https:\/\/doi.org\/10.1016\/j.repc.2017.07.010","relation":{},"ISSN":["0870-2551"],"issn-type":[{"value":"0870-2551","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-induced life-threatening arrhythmias and sudden cardiac death: A clinical perspective of long QT, short QT and Brugada syndromes","name":"articletitle","label":"Article Title"},{"value":"Revista Portuguesa de Cardiologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.repc.2017.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}